South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration’s 510(k) clearance for its latest AI-powered analysis software for screening lung nodules.The company develops AI imaging solutions for diagnosing various chest…
Continue Reading
A new study from Boston University found that experiences of racism can lead to a 26% greater risk of coronary heart disease in Black women. The study, which…
Continue Reading
By Mark Melchionna
March 02, 2023 – Recent research from Rutgers, the State University of New Jersey, described how artificial intelligence (AI) and machine learning (ML) could be used to examine genes within DNA,…
Eko SENSORA Cardiac Disease Detection Platform on tablet featuring 3M Littmann CORE Digital Stethoscope
“We’ve called it Shazam for heartbeats. You know Shazam, the music identification app that helps you figure out what song is…
A new study from the NYU Grossman School of Medicine shows how community health workers helped patients achieve optimal blood pressure control, underscoring the role these non-clinical workers play in chronic disease management. The…
Continue Reading
Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform. Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for…
Continue Reading
Developed using OpenAI’s ChatGPT and trained on healthcare-specific prose, the online DocsGPT offers doctors a chance to test and weigh in on AI-powered product development. Testing AI for workflow ‘scut’
OpenAI developed ChatGPT, which launched in…
To correct high blood pressure of the pulmonary artery, which can arise from congenital defects of the heart, an artificial heart ucan cost upwards of $190,000. Heart disease accounted for about one in five deaths in 2020 in theUnited States.
Even minimally invasive pulmonary artery banding — a surgical technique that has been in use since Harry Truman was president — requires access to the chest cavity. A new treatment under development by HeartPoint Global seeks to provide a minimally invasive alternative to current treatments for pulmonary arterial hypertension associated with Congenital Heart Disease.A device delivered through the leg would cost only…
Researchers at Wake Forest University School of Medicine have tested a closed-loop acoustic stimulation neurotechnology in its ability to treat insomnia. The device in question has been developed by Cereset, a medtech company headquartered in Arizona. Insomnia is not just unpleasant, but can have significant long-term health consequences, including an increased risk of cardiovascular disease, obesity, and diabetes. This technology works by monitoring brain waves through scalp sensors and then translating these waves into auditory tones that are played back to the wearer through ear buds. The researchers describe the technology as “allowing the brain to listen to itself”, leading […]…
Continue Reading
Doctors across India can now access an AI clinical decision support tool from Apollo Hospitals.Last year, the hospital chain launched the Apollo Clinical Intelligence Engine (CIE), a self-learning engine that analyses symptoms, determines causes, and helps recommend the best course of action.
The technology, which is built, maintained, and periodically reviewed by an in-house team of over 500 Apollo doctors and specialists, is capable of analysing huge amounts of data – it has over 1,300 conditions and 800 symptoms in its vocabulary at present – to help identify patterns that may be otherwise missed by manual diagnoses.
Built using four decades worth of hospital data,…
